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Various vitamins and vitamin-like substances inhibited the activity of poly(ADP-ribose) synthetase in vitro. The most potent were essential fatty 
acids, i.e. arachidonic acid, linoleic acid, and linolenic acid; their 50% inhibitory concentrations (IC,,) were 44110 pM, indicating a higher potency 
than nicotinamide, a well-known vitamin inhibitor (IC,, = 210 PM). Vitamins K,, K,, and retinal were the next strongest inhibitors, followed by 
a-lipoic acid, coenzyme Q,, and pyridoxal5-phosphate. Nicotinamide and vitamin K, exhibited mixed-type inhibition with respect to NAD+, while 
arachidonic acid exhibited dual inhibitions, competitive at 50 PM and mixed-type at 100 PM. 
Poly(ADP-ribose) synthesis; Enzyme inhibition; Vitamin; NAD; Arachidonate; ADP-ribosyltransferase 
1. INTRODUCTION 
Poly(ADP-ribose) synthetase (EC 2.4.2.30) is a 
nuclear enzyme that catalyzes DNA-dependent 
transfers of the ADP-ribose moiety of NADf to an ac- 
ceptor protein (chain initiation) and then to this 
protein-bound ADP-ribose (chain elongation) with a 
concomitant release of nicotinamide [I]. Various 
nuclear proteins, including histones, high-mobility 
group nonhistone proteins, and the enzyme itself [2,3], 
have been identified as acceptors of ADP-ribose in 
vitro as well as in vivo [l]. Many lines of evidence have 
suggested implications of poly(ADP-ribose) in DNA 
repair [4], cell differentiation [5,6], transformation [7], 
transcription [8], and formation of chromatin architec- 
ture [9,10]. These biological functions are most pro- 
bably regulated by some cellular factors, which remain 
to be found; so far, only DNA strand breaks have been 
known as a stimulator of the activity [4]. In search of 
other regulators, we took notice of the inhibitory ef- 
fects of nicotinamide, benzamide (a constituent of folic 
acid), and 1,4_naphthoquinone (a parent compound of 
vitamin KS) [ 111, and examined various vitamins and 
vitamin-like substances. We report here notable effects 
of unsaturated fatty acids, several vitamins and their 
derivatives on the synthetase activity. 
2. EXPERIMENTAL 
2.1. Enzymes and chemicals 
Poly(ADP-ribose) synthetase was purified from calf thymus as 
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previously described [12]. The enzyme was also purified from bovine 
thymus by Dr Y. Ohashi (Nara Medical College), and kindly donated 
to us. [Ade-%]NAD+ was obtained from Amersham International. 
All compounds tested for inhibition were of the highest grade com- 
mercially available. The purity (-100%) of vitamin Dz and a-lipoic 
acid was confirmed by thin-layer chromatography and proton 
nuclear magnetic resonance; the purity (>85%) of retinal was 
estimated by UV/VIS absorption and high-performance liquid 
chromatography. 
2.2. Poly(ADP-ribose) synfhetase assay 
The synthetase activity was assayed by measuring incorporation of 
“%I from [Ade-%]NAD+ into CljCCOOH-insoluble material. The 
reaction mixture (200~1) containing 100 mM Tris-HCI (pH 8.0), 
10 mM MgClz, 5 mM dithiothreitol, 32.5 /g/ml calf thymus DNA 
(sheared by sonication ten times for 10 s), 200pM [14C]NAD* 
(1.3-2.6 x 10’ cpm), enzyme (1.8 pg), and, if any, test compound 
was incubated for 10 min at 37°C. The reaction was terminated by 
the addition of 20% Cl,CCOOH. Acid-insoluble material was col- 
lected on a nitrocellulose filter (Millipore; HA type) or a glas fiber 
filter (Whatman; GF/C), and the filter was washed with 5% 
Cl$ZCOOH and examined for ?. Mode of inhibition was examined 
under standard conditions except the use of bovine thymus enzyme 
(1.5 kg) and the incubation for 30 s at 25°C. Compounds that were 
not completely water-soluble at 2 10 mM were first dissolved in 
dimethylsulfoxide (MesSO), and added into the reaction mixture. 
Quenching of scintillation by colored compounds was corrected for 
by the internal standardization method. 
3. RESULTS AND DISCUSSION 
Various vitamins and derivatives proved to be in- 
hibitory to the poly(ADP-ribose) synthetase activity 
(Table IA). Nicotinamide, a well-known inhibitor of 
this enzyme, was the strongest among vitamins 
established for humans. This compound, though 
documented as a competitive inhibitor [ 131, exhibited 
mixed-type inhibition with respect to NAD+ in our 
system (Fig. IA). We confirmed that a synthetic 
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Table I 
Effects of various vitamins and vitamin-like compounds on 
poly(ADP-ribose) synthetase activity 
Compound 
(A) 
Vitamin A (retinol)” 
Vitamin A acid (retinoic acid)” 
Vitamin A aldehyde (retinal)” 
Vitamin B, hydrochloride 
Vitamin Bza 
Vitamin Be, hydrochloride 
Pyridoxal 5-phosphatea 
D-Biotin” 
Folic acid” 
Nicotinic acid 
Nicotinamide 
D-Pantothenic acid sodium salt 
Vitamin Blza 
Vitamin C 
Vitamin DZ (calciferoBa 
Vitamin Dj (cholecalciferol)” 
Vitamin E (DL-Lu-tocopherol)a 
Vitamin K, (phytomenadione)b 
Vitamin Kz(20) (menatetrenone)a 
Vitamin Kj (menadioneja 
(B) 
p-Aminobenzoic acid sodium salt 
Arachidonic acid” 
DL-Carnitine chloride 
Choline chloride 
Coenzyme QO 
Hesperidin (vitamin P)” 
Inositol 
Linoleic acid” 
Linolenic acid” 
DL-cu-Lipoamide= 
DL-cu-Lipoic acid (oxidized form)a 
DL-ru-Lipoic acid (reduced form) 
DL-Methionine-S-methylsulfonium 
(vitamin U) chloride 
Orotic acid 
ICSO Inhibition (%) at 
CuM) 
1 mM 5mM 
_ 15 
_ > 3oc 
450 >70 
_ ~ Id 
_ 13 
_ 4 
4250 13 
_ 3 
_ 12 
_ 3 
210 72 
_ 2 
_ > 15 
_ -1 
_ >9 
_ >3 
>21 
520 >72 
_ -5 
420 >70 
_ 2 
44 >6J 
_ 0 
_ 5 
3900 -2 
_ 1 
_ -3 
48 85 
110 >JO 
_ 2 
3 
_ 58 
_ 8 
_ 6 
_ 
_ 
_ 
8 
_ 
10 
56 
8 
9 
87 
1 
_ 
8 
>I3 
>7 
>43 
_ 
>25 
>84 
7 
_ 
5 
8 
79 
26 
0 
_ 
_ 
>9 
34 
_ 
11 
24 
a 2% (final) MezSO 
b 10% (final) MezSO 
’ Minimum value estimated under conditions of limited solubility 
d Stimulation 
vitamin, K3, was a fairly strong inhibitor [14], and 
found that retinal (predominantly all-trans) and 
vitamin Kr were also fairly strong inhibitors. The 
potency of vitamin Kr and other water-insoluble 
vitamins might be underestimated in the presence of 
Me$SO; this solvent, a weak inhibitor by itself, general- 
ly reduces effects of other inhibitors (M. Banasik and 
K. Ueda, unpublished data). Pyridoxal 5phosphate 
and vitamin E were weaker inhibitors. Kinetic analysis 
indicated that vitamin K3 exhibited mixed-type inhibi- 
tion with respect to NAD+ (data not shown). 
Some vitamin-like compounds were also inhibitory 
to poly(ADP-ribose) synthetase (Table IB). 
Arachidonic acid was the most potent among com- 
(JJM) 
/ 60 
-6 -6 -4 -2 0 2 4 6 8 
1 /[NAD*] (mM_‘) 
X......I........, 
-0 -6 -4 -2 0 2 4 6 6 
I/[NAD+] (mM_‘) 
Fig. 1. Modes of inhibition of poly(ADP-ribose) synthetase activity 
by nicotinamide (A) and arachidonic acid (B). 
pounds tested in this study. It is noteworthy that this 
compound acted as a competitive inhibitor at 50 PM, 
while as a mixed-type inhibitor at 1OOpM (Fig. 1B). 
Spectrophotometric analysis indicated that arachidonic 
acid worked in a micelle form, rather than a 
monomeric form, in the reaction mixture, and the 
micelle state seemed to differ at 50 and 100 PM (data 
not shown). A sharp increase in inhibition between 25 
and 50 PM (Fig. 2) was in accord with the micelle for- 
mation in this concentration range. Two other essential 
fatty acids, i.e. linoleic acid and linolenic acid, were 
also strong inhibitors. Their ICSO values indicated that 
they were more potent than nicotinamide. Essentially 
no inhibition was observed with stearic acid, a 
saturated fatty acid, up to 5 mM (data not shown). The 
reduced form of Lu-lipoic acid exhibited 58% inhibition 
at 1 mM, whereas the oxidized form exhibited a much 
weaker effect even at 5 mM under standard conditions. 
When assayed without Mg’+, however, the oxidized 
form inhibited 81% of the activity at 5 mM, whereas 
the reduced form inhibited only 18% at I mM. This 
marked difference in the presence and absence of Mg2+ 
indicated that the reduced form of a-lipoic acid work- 
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Fig. 2. Inhibition of poly(ADP-ribose) synthetase activity by vitamin 
K1, nicotinamide, and arachidonic acid. Activity of 100% (no 
inhibition) represents incorporation of 1.4 nmol ADP-ribose under 
standard conditions. 
ed, at least partly, through chelation of this activator 
ion. Coenzyme Qo, a ubiquinone, was another in- 
hibitor. 
The mechanisms of physiological (or slow) actions of 
water-soluble vitamins are well understood, but those 
of lipophilic vitamins are not. The mechanisms of phar- 
macological (or rapid) actions of many vitamins also 
remain to be elucidated. Recent findings of direct ef- 
fects of vitamins on certain enzymes may give a clue to 
these unknown mechanisms; for example, retinal, 
retinoic acid, and unsaturated fatty acids, at a concen- 
tration range of lo-100/M, activate [15-171, while 
vitamin E inhibits the protein kinase C activity in vitro 
[ 181. In the present study, we found another direct ac- 
tion of vitamins, i.e. inhibition of the poly(ADP- 
ribose) synthetase activity. 
Whether our in vitro observations have any 
physiological significance awaits further investigation 
of metabolism, transport, and, in particular, local con- 
centrations of vitamins. Another useful approach to 
this problem might be analysis of cultured cells. Our 
preliminary experiments have shown that retinal, 
nicotinamide, arachidonic acid, and a-lipoic acid in- 
duce murine teratocarcinoma cell differentiation into 
epitheloid cells in culture, though less efficiently than 
retinoic acid [6] (K. Ueda and M. Banasik, unpublished 
results). Thus it seems possible that these vitamins 
share, at least partly, a common mechanism, such as 
suppression of poly(ADP-ribose) synthesis, in induc- 
tion of cell differentiation. 
In addition to poly(ADP-ribose) synthetase examin- 
ed in this study, an arginine- and monomer-specific 
ADP-ribosyltransferase from hen liver [19] has been 
found to be inhibited by several vitamins (e.g. K3) or 
vitamin-like substances (e.g. arachidonic acid), but not 
by others (e.g. nicotinamide) (M. Banasik, H. Komura, 
M. Shimoyama, and K. Ueda, manuscript in prepara- 
tion). These results may shed light on intricate actions 
of vitamins or related molecules to the cell through 
modulation of different types of ADP-ribosylation 
reactions. 
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